In June 2019, the 2017 VDI guidelines, which for the first time define “medical grade plastics” along the entire value chain, will be published as a white paper. This conference will provide attendees with an understanding of the content of the new regulations, the motivation for publishing them and methods of implementation.
Speakers will include primary raw material manufacturers, compounders, processers, distributors and users. Dr Andreas Nixdorf, Business Development Manager Extractables and Leachables Testing at SGS, will join a panel of experts and present on “Avoidance of Non-Intentionally Added Substances (NIAS) in plastic materials.”
There will be a presentation on measures for product and process control in the manufacture of medical devices and a discussion on developments in biocompatibility requirements and tests (ISO DIN 10993).
The conference is aimed at specialists and executives who are involved with the development, manufacture, distribution or purchase of plastic products for the medical sector.
Join us and find out what the new regulations mean for your company.
For more information, please contact:
Global Marketing Manager – Life Sciences
m: +44 7889 939 512